Integer Holdings Corporation

Integer Holdings Corporation is a medical device contract development and manufacturing organization (CDMO) that serves global medical device original equipment manufacturers (OEMs). The company offers a broad portfolio of products and services across multiple therapeutic areas, including interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. Integer also provides cardiac rhythm management products such as implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, and heart failure therapies. Additionally, its portfolio includes neuromodulation products like implantable spinal cord stimulators, as well as components such as non-rechargeable batteries, feedthroughs, device enclosures, and lead components. The company also supplies orthopedic, minimally invasive surgery, and general surgery devices, along with portable medical devices including patient monitors, ventilators, portable defibrillators, portable ultrasound, and X-ray machines.

Integer Holdings Corporation is publicly traded on the New York Stock Exchange (NYSE) under the ticker symbol ITGR. The company's shares are denominated in United States Dollars (USD), reflecting its primary listing in the United States. As a U.S.-based company, its financial reporting and stock trading are conducted in USD, making it accessible to investors through major brokerage platforms that trade on the NYSE.

Integer Holdings Corporation operates in the Healthcare sector, specifically within the Medical Devices industry. This classification reflects the company's focus on designing, developing, and manufacturing medical devices and components for a wide range of clinical applications. As a contract development and manufacturing organization (CDMO), Integer supports medical device OEMs by providing end-to-end solutions, from product design and development to high-volume manufacturing. The company's expertise spans multiple therapeutic areas, including cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical devices.

Integer Holdings Corporation is headquartered in the United States, as indicated by its country of incorporation. The company operates globally, serving multi-national OEMs and their affiliated subsidiaries across various regions. Its products and services are utilized in markets worldwide, with a particular focus on the United States and other developed healthcare markets. Integer's global presence allows it to support medical device companies in bringing innovative therapies to patients around the world, leveraging its manufacturing capabilities and regulatory expertise.

Integer Holdings Corporation operates as a contract development and manufacturing organization (CDMO) for the medical device industry. The company generates revenue by providing design, development, and manufacturing services to medical device OEMs. Its business model is built on long-term partnerships with customers, offering a comprehensive range of services from concept to commercialization. Integer's portfolio includes implanted medical devices, implanted leads, procedure accessories, external devices, and various components such as rechargeable and non-rechargeable batteries, feedthroughs, device enclosures, and machined components. The company also supplies medical stamped components, shallow and deep draw casings and assemblies, and epicardial pacing leads. By serving multiple therapeutic segments—including cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical devices—Integer diversifies its revenue streams and mitigates risks associated with any single product line.